Term Description

The National Health and Nutrition Examination Survey (NHANES) 2007-2008 Laboratory Procedure Manual documents the steps to draw the respondent's blood, process and store the serum, and measure the concentration of alkaline phosphatase in international units per liter (IU/L ). The manual also includes information for safety precautions, quality control, and reference ranges for normal values. The Skin, Bone, Muscle and Joint Working Group recommends obtaining a total plasma alkaline phosphatase level when the presence of Paget's disease is suspected. There are many methods used to obtain alkaline phosphatase values. The 2007-2008 National Health and Nutrition Examination Survey (NHANES) used both the Beckman Synchron LX20 and Beckman UniCel® DxC800 Synchron, which yielded comparable results. Regardless of the method used, it is critical to know the reference ranges for that method so that the user can interpret the results of the bioassay.

Reference Information

TypeSourceReference
CitationConsensus measures for Phenotypes and ExposuresCenters for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINCNameR/O/CCardinalityExample UCUM Units
62898-2PhenX - alkaline phosphatase protocol 170101
Indent66177-7Do you have hemophilia?
Indent66178-5Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?
Indent66504-2Exclusion Criteria
Indent66180-1Was blood drawn?
Indent66181-9Was full sample obtained?
Indent8251-1Service comment
Indent8251-1Service comment
Indent66208-0Make of the equipment used to perform...
Indent74719-6Manufacturer of the equipment used
Indent66200-7Repeatability of the assay{ratio}
Indent66201-5Coefficient of variation for the assay{CV}

LOINC Names Get Info

Fully-Specified Name
PhenX - alkaline phosphatase protocol 170101:-:Pt:^Patient:-:PhenX
Long Common Name
PhenX - alkaline phosphatase protocol 170101
Short Name
Alkaline phosphatase proto

Part Model Get Info

  • Component
    PhenX - alkaline phosphatase protocol 170101
    LP112494-2
    • Analyte
      PhenX - alkaline phosphatase protocol 170101
      LP112494-2
      • Component Numerator
        PhenX - alkaline phosphatase protocol 170101
        LP112494-2
        • Component Numerator Core
          PhenX - alkaline phosphatase protocol 170101
          LP112494-2
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    -
    LP6769-6
  • Time
    Pt
    LP6960-1
  • System
    ^Patient
    LP310005-6
    • System Core
      NULL
       
    • Super System
      Patient
      LP6985-8
  • Scale
    -
    LP7747-1
  • Method
    PhenX
    LP95333-8

Survey Question

PX170101

Basic Attributes

Class
PANEL.PHENX
Type
Clinical
First Released
Version 2.36
Last Updated
Version 2.81 (MIN)
Change Reason
Release 2.81: Status: Changing PhenX Concept from Status = Trial to Active; Previous Releases: Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.
Panel Type
Panel

Member of these Panels

LOINCLong Common Name
62896-6PhenX domain - Skin, bone, muscle and joint

Language Variants Get Info

TagLanguageTranslation
el-GRGreek (Greece)PhenX - αλκαλική φωσφατάση πρωτόκολλο 170101:-:Pt:^Ασθενής:-:PhenX
Synonyms: - PANEL.PHENX PHENX PhenX - αλκαλική φωσφατάση πρωτόκολλο 170101 Pt Αλκαλική φωσφατάση Ασθενής
es-MXSpanish (Mexico)PhenX - protocolo de fosfatasa alcalina 170101:-:Punto temporal:^ Paciente:-:PhenX
it-ITItalian (Italy)PhenX - fosfatasi alcalina, protocollo:-:Pt:^Paziente:-:PhenX
Synonyms: Panel PhenX paziente PhenX Punto nel tempo (episodio)
ru-RURussian (Russian Federation)PhenX - щелочная фосфатаза протокол:-:ТчкВрм:^Пациент:-:PhenX
Synonyms: Точка во времени;Момент
zh-CNChinese (China)PhenX - 碱性磷酸酶方案 170101:-:时间点:^患者:-:PhenX
Synonyms: ALKP;ALP;AP;总碱性磷酸酯酶;总碱性磷酸酶;总碱磷酶;碱性磷酸酯酶;碱性磷酸酯酶.总计;碱性磷酸酶.总计;碱磷酶;碱磷酶.总计 Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 Consensus measures for Phenotypes and eXposures;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 PhenX - 碱磷酶方案 170101;PhenX - ALP方案;Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.PhenX;组套(组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目).PhenX;Consensus measures for Phenotypes and eXposures;PhenX;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标;PhenX 医嘱组 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 碱 磷酸单酯酶 磷酸酶 组 组合 组合医嘱 组合类 组套

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=62898-2
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/62898-2